Table 4.
Comorbidity | Total n (%) (N=2400) |
Group 1 n (%) (n=1200) |
Group 2 n (%) (n=1200) |
P value |
Present | 511 (21.3) | 297 (24.8) | 214 (17.8) | <0.001 |
Absent | 1889 (78.7) | 903 (75.2) | 986 (82.2) |
Ocular manifestation | Group 1 (n=1200) | Group 2 (n=1200) | ||||||
With comorbidities (n=297) |
Without comorbidities (n=903) |
With comorbidities (n=214) |
Without comorbidities (n=986) |
|||||
n | % | n | % | n | % | n | % | |
Present (n=168) | 57 | 19.2 | 87 | 9.6 | 6 | 2.8 | 18 | 1.8 |
Absent (n=2232) | 240 | 80.8 | 816 | 90.4 | 208 | 97.2 | 968 | 98.2 |
P value | <0.001 | 0.415 |